Citadel Advisors - ONCONOVA THERAPEUTICS INC ownership

ONCONOVA THERAPEUTICS INC's ticker is ONTXXXXX and the CUSIP is 68232V306. A total of 15 filers reported holding ONCONOVA THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 2.9%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of ONCONOVA THERAPEUTICS INC
ValueSharesWeighting
Q2 2018$20,000
+17.6%
49,078
+332.4%
0.00%
Q4 2017$17,000
-58.5%
11,350
-37.3%
0.00%
Q4 2016$41,00018,1000.00%
Other shareholders
ONCONOVA THERAPEUTICS INC shareholders Q4 2017
NameSharesValueWeighting ↓
TYNDALL CAPITAL PARTNERS L P 520,832$1,453,00078.80%
Boxer Capital, LLC 316,386$838,0000.38%
SABBY MANAGEMENT, LLC 392,023$1,039,0000.04%
Alambic Investment Management, L.P. 13,500$36,0000.01%
Weiss Multi-Strategy Advisers LLC 24,087$64,0000.00%
EAGLE GLOBAL ADVISORS LLC 16,680$44,0000.00%
NEXT Financial Group, Inc 0$00.00%
BANK OF AMERICA CORP /DE/ 2$00.00%
MANUFACTURERS LIFE INSURANCE COMPANY, THE 77$00.00%
CITIGROUP INC 1,187$3,0000.00%
View complete list of ONCONOVA THERAPEUTICS INC shareholders